1. The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?
   Alessandra Cinque et al, 2021, Biomedicines CrossRef
2. Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma
   Jeong Yoon Suh et al, 2022, The Korean Journal of Urological Oncology CrossRef
3. TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer
   Lubna Danish et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef
4. Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
   Harini Lakshminarayanan et al, 2020, Frontiers in Oncology CrossRef
5. Serum and Urine Biomarkers for Human Renal Cell Carcinoma
   A. L. Pastore et al, 2015, Disease Markers CrossRef
6. Renal tumor biomarkers (Review)
   Ovidiu Bratu et al, 2021, Experimental and Therapeutic Medicine CrossRef
7. Effect of trail C1595T variant and gene expression on the pathogenesis of non-small cell lung cancer
   Öncü Koç Erbaşoğlu et al, 2019, Libyan Journal of Medicine CrossRef
8. Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis
   Ruojing Wei et al, 2015, Cell Biochemistry and Biophysics CrossRef
9. Circulating nuclear factor-kappa B mediates cancer-associated inflammation in human breast and colon cancer
   Kundaktepe Papila et al, 2021, Journal of Medical Biochemistry CrossRef
10. The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer
    Natasha Ustyanovska Avtenyuk et al, 2020, International Journal of Molecular Sciences CrossRef
11. Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) loss in canine mammary carcinoma
    Soo‐Hyeon Kim et al, 2022, Veterinary and Comparative Oncology CrossRef